Article
Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
Stem cells translational medicine - 1 May 2016
Vrtovec Bojan, Sever Matjaz, Jensterle Mojca, Poglajen Gregor, Janez Andrej, Kravos Nika, Zemljic Gregor, Cukjati Marko, Cernelc Peter, Haddad François, Wu Joseph C, Jorde Ulrich P
Abstract excerpt
UNLABELLED: We evaluated the association of diabetes and insulin resistance with the response to cell therapy in patients with nonischemic dilated cardiomyopathy (DCM). A total of 45 outpatients with DCM received granulocyte colony-stimulating factor for 5 days. CD34(+) cells were then collected by apheresis and injected transendocardially. Twelve patients had diabetes mellitus (DM group), 17 had insulin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
